Your browser doesn't support javascript.
loading
Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer Cells.
Huang, Wei; Yuan, Xia; Sun, Ting; Fan, Shujie; Wang, Jun; Zhou, Quan; Guo, Wei; Ran, Fuxiang; Ge, Zemei; Yang, Huayu; Li, Runtao; Cui, Jingrong.
Afiliación
  • Huang W; Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical CollegeBeijing, China.
  • Yuan X; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking UniversityBeijing, China.
  • Sun T; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking UniversityBeijing, China.
  • Fan S; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking UniversityBeijing, China.
  • Wang J; Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical CollegeBeijing, China.
  • Zhou Q; Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical CollegeBeijing, China.
  • Guo W; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking UniversityBeijing, China.
  • Ran F; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking UniversityBeijing, China.
  • Ge Z; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking UniversityBeijing, China.
  • Yang H; Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking UniversityBeijing, China.
  • Li R; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing, China.
  • Cui J; Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking UniversityBeijing, China.
Front Pharmacol ; 8: 476, 2017.
Article en En | MEDLINE | ID: mdl-28883791
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: China